The Management of Acute Sarcoidosis is Based on Level of Symptoms and Extent of Organ Involvement - Flowchart
The Management of Acute Sarcoidosis is Based on Level of Symptoms and Extent of Organ Involvement - Flowchart
«Flowchart»

ALGORITHM FOR MANAGEMENT OF SARCOIDOSIS

ALGORITHM FOR MANAGEMENT OF SARCOIDOSIS

ALGORITHM FOR MANAGEMENT OF SARCOIDOSIS

ALGORITHM FOR MANAGEMENT OF SARCOIDOSIS LGORITHM FOR ANAGEMENT OF ARCOIDOSIS

Acute disease

Acute disease

Acute disease

Minimal to no symptoms

Minimal to no symptoms

Minimal to no symptoms

Single organ disease

Single organ disease

Single organ disease

Symptomatic multiple organs

Symptomatic multiple organs

Symptomatic multiple organs

End

End

End

Abnormalities of neurologic, cardiac, ocular, calcium

Abnormalities of neurologic, cardiac, ocular, calcium

Abnormalities of neurologic, cardiac, ocular, calcium

Yes: consider systemic therapy

Yes: consider systemic therapy

Yes

No: no therapy and observe

No: no therapy and observe

No

Affecting only: anterior eye, localized skin, cough

Affecting only: anterior eye, localized skin, cough

Affecting only: anterior eye, localized skin, cough

Yes: try topical steroids

Yes: try topical steroids

Yes

No: systemic therapy

No: systemic therapy

No

Consider methotrexate, hydroxychloroquine, azathioprine

Consider methotrexate, hydroxychloroquine, azathioprine

Consider methotrexate, hydroxychloroquine, azathioprine

Systemic therapy: glucocorticoids (e.g., prednisone)

Systemic therapy: glucocorticoids (e.g., prednisone)

Systemic therapy: glucocorticoids (e.g., prednisone)

Taper to <10 mg in <6 months: continue prednisone

Taper to <10 mg in <6 months: continue prednisone

Taper to <10 mg in <6 months

Cannot taper to <10 mg in 6 months or glucocorticoid toxicity

Cannot taper to <10 mg in 6 months or glucocorticoid toxicity

Cannot taper to <10 mg in 6 months